RegulatoryOfficial

EU and Japan's AMED to continue medical countermeasures cooperation on cross-border health threats

🇪🇺 European Commission (DG SANTE) · Mon 16 Nov 2026

DG HERA and Japan's AMED have confirmed by exchange of letters that they will keep working together under their 2023 arrangement on preparedness for serious cross-border infectious disease threats.

The European Commission, through its Health Emergency Preparedness and Response Authority (DG HERA), and the Japan Agency for Medical Research and Development (AMED) will continue their cooperation on medical countermeasures. The stated aim is to strengthen prevention, preparedness and response to serious cross-border health threats.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: European Commission (DG SANTE) ↗

Article written by VigiEye from the official source (European Commission (DG SANTE)). AI-assisted; check the source before acting.